Date published: 2026-4-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

MALT1 Inhibitors

MALT1 inhibitors belong to a distinctive chemical class renowned for their role in modulating cellular signaling pathways and fostering applications in various biomedical contexts. The acronym MALT1 stands for Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1, denoting a crucial enzyme implicated in signal transduction and immune response regulation. These inhibitors are designed to impede the enzymatic activity of MALT1, which functions as a protease that cleaves specific proteins and orchestrates downstream cellular events. MALT1 is predominantly recognized for its involvement in the NF-κB (Nuclear Factor kappa-light-chain-enhancer of activated B cells) pathway, a paramount signaling cascade that regulates diverse cellular processes, including immune responses, inflammation, and cell survival. Structurally, MALT1 inhibitors are meticulously crafted to interact with the active site of the MALT1 enzyme, thereby obstructing its proteolytic function. This engagement interferes with the proteolytic cleavage of critical protein substrates and subsequently disrupts the downstream signaling events that rely on these cleavage products. The chemical class of MALT1 inhibitors encompasses a variety of compounds, each displaying distinct molecular architectures tailored to engage with the enzyme's active site with varying affinities and selectivities. Researchers have painstakingly explored the molecular interactions between these inhibitors and MALT1, aiming to decipher the intricate mechanisms governing enzyme inhibition and downstream effects.In summary, MALT1 inhibitors represent a prominent class of compounds with intricate designs focused on attenuating the enzymatic activity of MALT1. By targeting this enzyme, these inhibitors have the ability to modulate crucial signaling pathways, thereby holding promise for diverse applications across the biomedical field. Their intricate molecular structures and strategic interactions with MALT1's active site underscore the complexity of their design and the depth of research aimed at unraveling their functional mechanisms.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Z-VRPR-FMK

1217481-41-8 (free base)sc-396657
500 µg
$288.00
1
(1)

Z-VRPR-FMK is a potent inhibitor of MALT1, a key regulator in the NF-κB signaling pathway. This compound selectively binds to the active site of MALT1, disrupting its proteolytic activity and preventing the cleavage of downstream substrates. Its unique structure allows for high specificity, influencing the kinetics of MALT1-mediated signaling. By modulating these pathways, Z-VRPR-FMK can significantly alter cellular responses to stimuli, showcasing its role in cellular signaling dynamics.

Acalabrutinib

1420477-60-6sc-507392
250 mg
$255.00
(0)

Known as a BTK inhibitor, it also impacts MALT1 and is researched for lymphoma and autoimmune disorders.